NEW YORK (GenomeWeb) – Life sciences tools startup Ultivue announced today that it has closed a $5.2 million Series A financing round that included Arch Venture Partners, Hansjoerg Wyss, and several private investors.

The company was founded to commercialize two fluorescence microscopy technologies, called DNA-PAINT and DNA-Exchange, developed at Harvard University's Wyss Institute for Biologically Inspired Engineering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.